Cutaneous leukocytoclastic vasculitis secondary to COVID-19 infection leading to extensive skin necrosis

[1]  A. Ramanan,et al.  COVID-19 vasculitis and novel vasculitis mimics , 2021, The Lancet Rheumatology.

[2]  H. Galehdari,et al.  Cutaneous leukocytoclastic vasculitis secondary to COVID‐19 infection: A case report , 2020, Clinical case reports.

[3]  Y. Tam,et al.  Skin manifestations of COVID-19: A worldwide review , 2020, JAAD International.

[4]  M. Barberá,et al.  Leucocytoclastic vasculitis in a patient with COVID-19 with positive SARS-CoV-2 PCR in skin biopsy , 2020, BMJ Case Reports.

[5]  J. Connors,et al.  The coagulopathy, endotheliopathy, and vasculitis of COVID-19 , 2020, Inflammation Research.

[6]  A. Tahir,et al.  Widespread cutaneous small vessel vasculitis secondary to COVID‐19 infection , 2020, International journal of dermatology.

[7]  R. Becker.  COVID-19-associated vasculitis and vasculopathy , 2020, Journal of Thrombosis and Thrombolysis.

[8]  F. Rongioletti,et al.  A generalized purpuric eruption with histopathologic features of leucocytoclastic vasculitis in a patient severely ill with COVID‐19 , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[9]  P. Burgos-Blasco,et al.  Cutaneous small‐vessel vasculitis associated with novel 2019 coronavirus SARS‐CoV‐2 infection (COVID‐19) , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[10]  D. Montero Vega,et al.  Cutaneous small vessel vasculitis secondary to COVID‐19 infection: A case report , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[11]  B. Lipworth,et al.  Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19 , 2020, Journal of Allergy and Clinical Immunology.

[12]  C. A. González-Cruz,et al.  Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases , 2020, The British journal of dermatology.

[13]  R. Assaly,et al.  Elevated interleukin‐6 and severe COVID‐19: A meta‐analysis , 2020, Journal of medical virology.

[14]  P. Mehta,et al.  COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.

[15]  G. Navis,et al.  Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.